FreeThink Technologies, Inc., a leading research laboratory in pharmaceutical development, proudly announces the successful completion of a U.S. Food and Drug Administration (FDA) inspection at its analytical and formulation development laboratories in Branford, CT.
The rigorous inspection confirms FreeThink’s compliance with Current Good Manufacturing Practices (cGMP). President Kenneth Waterman, Ph.D. said “The successful FDA inspection represents a significant milestone for FreeThink. It is a testament to our unwavering commitment to world-class quality, continuous improvement, and the highest standards of safety and efficacy in all our operations.”
FreeThink offers services under cGMP, including cGMP ASAP studies using ASAPprime® for rapid product shelf life determination. FreeThink is committed to using world-class science to speed better products to market.
About FreeThink Technologies, Inc. (“FreeThink”)
FreeThink is a contract laboratory that serves the pharmaceutical, biotech, diagnostic and medical device, and consumer products sectors. FreeThink has been operating for nearly 15 years and takes pride in its’ fast, communicative, and science-based approach.
FreeThink specializes in the following:
- ASAPprime® Stability Software
- ADAP: Rapid Formulation Development
- Shelf Life Determination and Packaging Selection
- OsmoCAP® Extended-Release Osmotic Capsules
For more information please visit freethinktech.com, call 860-237-5800, or email david.lucey@freethinktech.com.
FreeThink Technologies, Inc.
688 East Main Street
Branford, CT 06405